XML 96 R45.htm IDEA: XBRL DOCUMENT v3.22.0.1
Organization (Narrative) (Details) - USD ($)
1 Months Ended 12 Months Ended
Apr. 30, 2019
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Noncontrolling Interest [Abstract]        
Exercise of options and related tax benefit $ 1,000,000      
Net loss at subsidiary allocated to noncontrolling interests   $ 95,212 $ 79,496 $ 8,752
Cumberland Emerging Technologies, Inc (CET)        
Noncontrolling Interest [Abstract]        
Noncontrolling interest, ownership percentage by parent   85.00%    
HongKong WinHealth Pharma Group Co. Limited        
Noncontrolling Interest [Abstract]        
Investment in CET 1,000,000      
Contribution of cash 300,000      
Conversion of intercompany loans payable 700,000      
Gloria Pharmaceuticals        
Noncontrolling Interest [Abstract]        
Exchange for consideration, amount $ 800,000      
Cumberland Emerging Technologies, Inc (CET) | Harbin Gloria Pharmaceuticals Co        
Noncontrolling Interest [Abstract]        
Exercise of options and related tax benefit   $ 1,000,000